| Literature DB >> 20800401 |
Valentina Ambrosini1, Davide Campana, Paola Tomassetti, Gaia Grassetto, Domenico Rubello, Stefano Fanti.
Abstract
In the present review article we presented the major technical innovations regarding the diagnosis of NET with PET/CT 68Ga-DOTA-peptides compounds over conventional radiologic and scintigraphic imaging, discussing both the different types of radiopharmaceuticals commercially available, trying to making a comparison on the possible advantages and drawbacks of these radiopharmaceuticals, and providing also some technical recommendations to the radiologists and nuclear physicians for using these new methodology in an appropriate manner in the clinical setting.Entities:
Mesh：
Substances：
Year: 2010 PMID： 20800401 DOI： 10.1016/j.ejrad.2010.07.022
Source DB: PubMed Journal: Eur J Radiol ISSN： 0720-048X Impact factor: 3.528